TransCode Therapeutics, Inc. (NASDAQ:RNAZ) People

TransCode Therapeutics, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Elizabeth Czerepak
Other companies: Delcath Systems, Inc. (DIRECTOR · Since at least Feb 14, 2020); Scilex Holding Company (See Remarks · Nov 10, 2022 – Jan 17, 2023 · Past); Sorrento Therapeutics, Inc. (EVP & Chief Financial Officer · Nov 15, 2021 – May 18, 2022 · Past); Spectrum Pharmaceuticals Inc (Director · Jun 19, 2019 – Jun 18, 2020 · Past)
CFO, Director · Since at least Oct 6, 2025
Anna MooreChair of Scientific Advisory Board · Since at least Apr 27, 2026
Erik MantingDirector · Since at least Nov 5, 2026
Jack E. StoverDirector · Since at least Dec 22, 2025
John TattoryInterim CFO · Since at least Sep 10, 2026
Karrie HilsingerVP of Clinical Operations · Since at least Nov 4, 2026
Magda MarquetDirector · Since at least Dec 22, 2025
Michel JanicotConsulting Head of Translational Science · Since at least Nov 17, 2025
Philippe CalaisCEO · Since at least Oct 28, 2026
Tania Montgomery-HammonVP, Business Development · Since at least Oct 13, 2026
Zdravka MedarovaCofounder/Chief Scientific Officer · Since at least Oct 19, 2026